The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

4D Pharma Plc ADR Adma Biologics Adverum Biotechnologies Inc Agile Therapeutics Inc Alzamend Neuro Inc Applied Genetic Tech Applied Molecular Transport Inc Aptose Bioscns Aridis Pharmaceuticals Inc Astrazeneca Plc ADR Athersys Inc Biohaven Ltd Biontech Se ADR Biovie Inc Black Diamond Therapeutics Inc Bristol-Myers Squibb Centessa Pharmaceuticals Plc ADR Chemomab Therapeutics Ltd ADR Clarus Therapeutics Hldgs Inc Clearside Biomedi Cns Pharmaceuticals Inc Cue Health Inc Cullinan Therapeutics Inc Cytokinetics Eagle Pharmaceuticals Eiger Biopharma Eledon Pharmaceuticals Inc Emergent Biosolutions Entera Bio Ltd Exscientia Ltd ADR First Wave Biopharma Inc Forte Biosciences Inc Galapagos NV ADR Gilead Sciences Global Blood Ther Graybug Vision Inc Haemonetics Corp Harpoon Therapeutics Inc Hookipa Pharma Inc Humanigen Inc Imara Inc Inozyme Pharma Inc Ionis Pharmaceuticals Jasper Therapeutics Inc. Kala Bio Inc Leap Therapeutics Inc Legend Biotech Corp ADR Lumiradx Ltd Merck & Co Morphosys Ag ADR Nanobiotix S.A. ADR Nasdaq Biotechnology Ishares ETF Nautilus Biotechnology Inc Nextcure Inc Orchard Therapeutics Plc ADR Pliant Therapeutics Inc Precigen Inc Redhill Biophrma ADR Regenxbio Inc Renaissance International IPO ETF Renovorx Inc Silverback Therapeutics Inc Spruce Biosciences Inc Tcr2 Therapeutics Inc Titan Pharma Tiziana Life Sciences Ltd Vaccitech Plc ADR Voyager Therapeut Vyne Therapeutics Inc Zynex Inc